PD19-04 THE PROSTATIC URETHRAL LIFT (UROLIFT) VERSUS THE THERMAL WATER VAPOR ABLATION (REZūM) FOR MINIMALLY INVASIVE TREATMENT OF BPH: A COMPARISON OF IMPROVEMENTS AND DURABILITY IN 3-YEAR CLINICAL OUTCOMES

INTRODUCTION AND OBJECTIVES:The minimally invasive radiofrequency thermal water vapour thermal therapy (Rezum) and the prostatic lift (Urolift) procedures offer minimally-invasive treatment for lower urinary tract symptoms (LUTS) associated with benign prostate hyperplasia. Rezum is a novel treatment modality that has demonstrated safety and efficacy in patients with LUTS. There have been no published head-to-head comparisons of the relative efficacy of the Rezum and Urolift systems. We report an indirect analysis of clinical symptoms and quality of life of two previously published studies of three year outcomes.METHODS:Clinical outcomes were obtained from published prospective data. International Prostate Symptom Score (IPSS) and IPSS - Quality of Life (QoL), Maximum flow rate (Q-max), post-void residual volume (PVR), Benign Prostate Hyperplasia Impact Index (BPHII) scores along with MSHQ-EjD function and bother domains were outcomes of interest. Outcomes were assessed at 3, 12, 24, and 36 months. The In...